Gainers
Annovis Bio, Inc. (NASDAQ: ANVS) shares surged 127.3% to close at $60.00 on Friday after the company announced new results from a Phase 2 study evaluating its lead drug candidate, ANVS401, for Alzheimer's disease (AD), Parkinson's disease (PD). Participants treated with ANVS401 for 25 days showed statistically significant cognitive improvement, as per Alzheimer's cognitive subscale (ADAS-Cog11).
Obalon Therapeutics, Inc. (NASDAQ: OBLN) gained 30% to settle at $3.42. Obalon Therapeutics recommended stockholders vote for all proposals related to merger with ReShape Lifesciences.
Resonant Inc. (NASDAQ: RESN) rose 23.5% to close at $3.58. The company recently reported quarterly results.
Gracell Biotechnologies Inc. (NASDAQ: GRCL) climbed 20.7% to close at $17.61. Gracell Biotechnologies is scheduled to host clinical update conference call and webcast on June 4, 2021.
Mesa Royalty Trust (NYSE: MTR) jumped 20.3% to close at $5.58.
Lightbridge Corporation (NASDAQ: LTBR) gained 18.8% to settle at $6.27. The company recently reported a narrower quarterly loss.
Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) jumped 18.1% to close at $8.95. The company, earlier during the month, priced its IPO at $7 per share.
Great Elm Group, Inc. (NASDAQ: GEG) gained 17.5% to close at $2.82. Great Elm Group 10%+ owner Long Ball Partners reported purchase of 328,686 shares at an average price of $2.38 per share in Form 4 Filing on Thursday.
Kuke Music Holding Limited (NYSE: KUKE) rose 16.5% to settle at $6.20 following Q1 results.
NetSol Technologies, Inc. (NASDAQ: NTWK) gained 16.1% to close at $4.83.
BRF S.A. (NYSE: BRFS) rose 15.8% to close at $5.05.
Ideal Power Inc. (NASDAQ: IPWR) gained 15.1% to settle at $11.73. The company recently posted a narrower quarterly loss.
Wah Fu Education Group Limited (NASDAQ: WAFU) shares surged 15% to close at $7.70 following news from Meten EdtechX Education student enrollment for its English-language training classes were up more than 750% year over year in April.
EuroDry Ltd. (NASDAQ: EDRY) gained 15% to close at $17.08. The company recently posted upbeat quarterly results.
PDS Biotechnology Corporation (NASDAQ: PDSB) surged 14.6% to settle at $8.33 fter the company announced the release of the abstract for ...Full story available on Benzinga.com
Benzinga
